Preferential transmission of interleukin-1 receptor antagonist alleles in attention deficit hyperactivity disorder

被引:0
|
作者
Segman R.H. [1 ]
Meltzer A. [2 ]
Gross-Tsur V. [3 ]
Kosov A. [4 ]
Frisch A. [4 ]
Inbar E. [5 ]
Darvasi A. [5 ]
Levy S. [2 ]
Goltser T. [1 ]
Weizman A. [4 ]
Galili-Weisstub E. [2 ]
机构
[1] Department of Psychiatry, Hadassah-Hebrew University Medical Center, Jerusalem
[2] Child and Adolescent Psychiatry Unit, Hadassah-Hebrew University Medical Center, Jerusalem
[3] Neuropediatric Unit, Shaare Zedek Medical Center, Jerusalem
[4] Geha Psychiatric Hospital, Petah Tikva and Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University
[5] Life Sciences Institute, The Hebrew University, Jerusalem
关键词
ADHD; Attention deficit hyperactivity disorder; Interleukin-1 receptor antagonist gene; Transmission disequilibrium test;
D O I
10.1038/sj.mp.4000919
中图分类号
学科分类号
摘要
Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, where family data support substantial heritability. To date, association studies focussed mainly on genes regulating dopaminergic neurotransmission. Interleukin-1 (IL-1) activity in the brain has been implicated with differentiation of dopaminergic neurons and modulation of central monoaminergic reactivity. We investigated the role of interleukin-1 receptor antagonist (IL-1Ra) gene variable number tandem repeat (VNTR) polymorphism, in a sample of 86 children with DSM-IV ADHD and their parents. Transmission disequilibrium analysis showed increased transmission of the IL-1Ra 4-repeat allele (χ2 = 4.07, P = 0.04) and decreased transmission of the 2-repeat allele (χ2 = 4.59, P = 0.03) to affected children. The 4-repeat allele was associated with a significantly increased risk for ADHD (χ2 = 4.46, df 1, P= 0.035, RR = 1.292, 95% CI 1.01-1.66). The IL-1Ra 2-repeat allele was associated with a significantly decreased risk for ADHD (χ2 = 4.65, df 1, P = 0.03, RR = 0.763, 95% CI 0.59-0.98). If replicated, this finding may point to a role for brain cytokine activity in the etiopathogenesis of ADHD.
引用
收藏
页码:72 / 74
页数:2
相关论文
共 50 条
  • [41] Attention deficit hyperactivity disorder
    Carboni, Alejandra
    [J]. PSICOLOGIA CONOCIMIENTO Y SOCIEDAD, 2011, 1 (03): : 95 - 131
  • [42] Attention Deficit Disorder with Hyperactivity
    Coudert, Pascal
    Rubat, Catherine
    [J]. ACTUALITES PHARMACEUTIQUES, 2011, 50 (508): : 23 - 28
  • [43] Attention deficit hyperactivity disorder
    不详
    [J]. PREVENTIVE MEDICINE, 2001, 33 (03) : 153 - 154
  • [44] Attention Deficit and Hyperactivity Disorder
    Fawns, Tina
    [J]. PRIMARY CARE, 2021, 48 (03): : 475 - 491
  • [45] Attention Deficit/Hyperactivity Disorder
    Sagvolden, Terje
    [J]. EUROPEAN PSYCHOLOGIST, 1999, 4 (02) : 109 - 114
  • [46] Attention Deficit Hyperactivity Disorder
    Bendak, Lama
    [J]. WORLD FAMILY MEDICINE, 2011, 9 (03): : 25 - 28
  • [47] Attention Deficit Hyperactivity Disorder
    Madhuri Kulkarni
    [J]. The Indian Journal of Pediatrics, 2015, 82 : 267 - 271
  • [48] Attention deficit hyperactivity disorder
    Prahbhjot Malhi
    Pratibha Singhi
    [J]. The Indian Journal of Pediatrics, 2003, 70 (11) : 883 - 884
  • [49] Predictors of interleukin-1β and interleukin-1 receptor antagonist in infant saliva
    Miller, Elizabeth M.
    [J]. AMERICAN JOURNAL OF HUMAN BIOLOGY, 2021, 33 (03)
  • [50] INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS THE HYPERCALCEMIA MEDIATED BY INTERLEUKIN-1
    GUISE, TA
    GARRETT, IR
    BONEWALD, LF
    MUNDY, GR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 (05) : 583 - 587